FDA de­lays Kad­mon’s pri­or­i­ty re­view as ap­par­ent clam­p­down con­tin­ues

Kad­mon Hold­ings just lost their pri­or­i­ty re­view.

The im­munol­o­gy biotech an­nounced Wednes­day that the FDA has pushed back the de­ci­sion date for their graft-ver­sus-host dis­ease …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER